Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$24.92 - $30.02 $114,706 - $138,182
-4,603 Reduced 19.96%
18,455 $463,000
Q4 2023

Jan 25, 2024

BUY
$27.14 - $34.93 $678 - $873
25 Added 0.11%
23,058 $680,000
Q3 2023

Oct 27, 2023

BUY
$24.63 - $32.85 $567,302 - $756,634
23,033 New
23,033 $727,000
Q2 2023

Jul 18, 2023

BUY
$23.51 - $30.09 $132,996 - $170,219
5,657 Added 15.53%
42,086 $1.09 Million
Q1 2023

Apr 13, 2023

BUY
$19.19 - $24.1 $678,308 - $851,862
35,347 Added 3266.82%
36,429 $875,000
Q4 2022

Jan 23, 2023

SELL
$17.59 - $23.83 $422 - $571
-24 Reduced 2.17%
1,082 $0
Q3 2022

Oct 26, 2022

BUY
$19.98 - $29.44 $22,097 - $32,560
1,106 New
1,106 $23,000

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.61B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.